Comparing CT-guided and Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Treating Idiopathic Trigeminal Neuralgia in Adults Aged 18 to 60

What this Trial Is About

Researchers are evaluating the effectiveness and safety of CT-guided versus fluoroscopy-guided trigeminal ganglion radiofrequency thermocoagulation TG-RFT in treating adults aged 18 to 60 with idiopathic trigeminal neuralgia TN. This condition involves severe, recurring facial pain, and the study aims to determine which imaging method provides better pain relief, affects medication use differently, and has fewer procedure-related side effects. Participants will be randomly assigned to receive either CT-guided TG-RFT, which uses real-time CT imaging to guide needle placement, or fluoroscopy-guided TG-RFT, which uses fluoroscopic imaging. Both procedures are done under sterile conditions with appropriate monitoring and anesthesia. After the procedure, participants will be followed for pain relief and side effects at 1, 3, and 6 months. During the study, participants will undergo pain assessments using the Numeric Rating Scale NRS and Visual Analog Scale VAS at several time points including baseline, immediately after the procedure, and during follow-up visits. Medication use will be tracked at 6 months, and any procedure-related adverse events will be recorded throughout. The total involvement spans the procedure and follow-up assessments over six months.

CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia